• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米技术的发展中国家常见疾病诊断:即时检测的当前进展

Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests.

作者信息

Thwala Lungile Nomcebo, Ndlovu Sphumelele Colin, Mpofu Kelvin Tafadzwa, Lugongolo Masixole Yvonne, Mthunzi-Kufa Patience

机构信息

National Laser Centre, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa.

College of Agriculture, Engineering and Science, School of Chemistry and Physics, University of Kwa-Zulu Natal, University Road, Westville, Durban 3630, South Africa.

出版信息

Nanomaterials (Basel). 2023 Mar 31;13(7):1247. doi: 10.3390/nano13071247.

DOI:10.3390/nano13071247
PMID:37049340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10096522/
Abstract

The introduction of point-of-care testing (POCT) has revolutionized medical testing by allowing for simple tests to be conducted near the patient's care point, rather than being confined to a medical laboratory. This has been especially beneficial for developing countries with limited infrastructure, where testing often involves sending specimens off-site and waiting for hours or days for results. However, the development of POCT devices has been challenging, with simplicity, accuracy, and cost-effectiveness being key factors in making these tests feasible. Nanotechnology has played a crucial role in achieving this goal, by not only making the tests possible but also masking their complexity. In this article, recent developments in POCT devices that benefit from nanotechnology are discussed. Microfluidics and lab-on-a-chip technologies are highlighted as major drivers of point-of-care testing, particularly in infectious disease diagnosis. These technologies enable various bioassays to be used at the point of care. The article also addresses the challenges faced by these technological advances and interesting future trends. The benefits of point-of-care testing are significant, especially in developing countries where medical care is shifting towards prevention, early detection, and managing chronic conditions. Infectious disease tests at the point of care in low-income countries can lead to prompt treatment, preventing infections from spreading.

摘要

即时检验(POCT)的引入彻底改变了医学检验方式,它使简单的检测能够在患者护理点附近进行,而不必局限于医学实验室。这对基础设施有限的发展中国家尤为有益,在这些国家,检测通常需要将样本送到外地,并等待数小时或数天才能得到结果。然而,POCT设备的开发一直具有挑战性,简单性、准确性和成本效益是使这些检测可行的关键因素。纳米技术在实现这一目标方面发挥了至关重要的作用,它不仅使检测成为可能,还掩盖了其复杂性。本文讨论了受益于纳米技术的POCT设备的最新进展。微流体和芯片实验室技术被视为即时检验的主要驱动力,特别是在传染病诊断方面。这些技术使各种生物测定能够在护理点使用。本文还讨论了这些技术进步所面临的挑战以及有趣的未来趋势。即时检验的好处是巨大的,特别是在医疗保健正朝着预防、早期检测和慢性病管理转变的发展中国家。在低收入国家的护理点进行传染病检测可以实现及时治疗,防止感染传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/a1b972be5344/nanomaterials-13-01247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/b7ee04485fe0/nanomaterials-13-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/d8bc53b3d9ee/nanomaterials-13-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/2b62ee05977f/nanomaterials-13-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/f0a470dfac52/nanomaterials-13-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/dfa2207a412a/nanomaterials-13-01247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/a1b972be5344/nanomaterials-13-01247-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/b7ee04485fe0/nanomaterials-13-01247-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/d8bc53b3d9ee/nanomaterials-13-01247-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/2b62ee05977f/nanomaterials-13-01247-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/f0a470dfac52/nanomaterials-13-01247-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/dfa2207a412a/nanomaterials-13-01247-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/34b8/10096522/a1b972be5344/nanomaterials-13-01247-g006.jpg

相似文献

1
Nanotechnology-Based Diagnostics for Diseases Prevalent in Developing Countries: Current Advances in Point-of-Care Tests.基于纳米技术的发展中国家常见疾病诊断:即时检测的当前进展
Nanomaterials (Basel). 2023 Mar 31;13(7):1247. doi: 10.3390/nano13071247.
2
Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.基于微流控技术的即时检测(POCT)设备应对新冠疫情浪潮:新兴解决方案
ACS Appl Bio Mater. 2022 May 16;5(5):2046-2068. doi: 10.1021/acsabm.1c01320. Epub 2022 Apr 27.
3
Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.在资源匮乏和分散的环境中进行病毒性肝炎即时检测的创新技术。
J Viral Hepat. 2018 Feb;25(2):108-117. doi: 10.1111/jvh.12827. Epub 2017 Dec 27.
4
Point-of-Care Testing即时检验
5
Nucleic-acid testing, new platforms and nanotechnology for point-of-decision diagnosis of animal pathogens.用于动物病原体即时诊断的核酸检测、新平台及纳米技术
Methods Mol Biol. 2015;1247:253-83. doi: 10.1007/978-1-4939-2004-4_20.
6
Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.物联网医疗(IoMT)集成生物传感器,用于即时检测传染病。
Biosens Bioelectron. 2021 May 1;179:113074. doi: 10.1016/j.bios.2021.113074. Epub 2021 Feb 6.
7
Microfluidic Point-of-Care Testing: Commercial Landscape and Future Directions.微流控即时检测:商业前景与未来方向。
Front Bioeng Biotechnol. 2021 Jan 15;8:602659. doi: 10.3389/fbioe.2020.602659. eCollection 2020.
8
Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing.用于即时检测的基于纳米材料的生物传感器的最新趋势
Front Chem. 2020 Oct 16;8:586702. doi: 10.3389/fchem.2020.586702. eCollection 2020.
9
Point of Care Testing for Infectious Disease in Europe: A Scoping Review and Survey Study.欧洲即时检测传染病:范围综述和调查研究。
Front Public Health. 2021 Oct 20;9:722943. doi: 10.3389/fpubh.2021.722943. eCollection 2021.
10
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.

引用本文的文献

1
Nanomedicine: The Effective Role of Nanomaterials in Healthcare from Diagnosis to Therapy.纳米医学:纳米材料在从诊断到治疗的医疗保健中的有效作用。
Pharmaceutics. 2025 Jul 30;17(8):987. doi: 10.3390/pharmaceutics17080987.
2
Kim-1-targeted multimodal nanoprobes for early diagnosis and monitoring of sepsis-induced acute kidney injury.用于脓毒症诱导的急性肾损伤早期诊断和监测的靶向Kim-1的多模态纳米探针。
Apoptosis. 2025 Jul 23. doi: 10.1007/s10495-025-02141-w.
3
Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D.

本文引用的文献

1
Metal-Oxide Nanomaterials Synthesis and Applications in Flexible and Wearable Sensors.金属氧化物纳米材料的合成及其在柔性和可穿戴传感器中的应用
ACS Nanosci Au. 2021 Nov 29;2(2):64-92. doi: 10.1021/acsnanoscienceau.1c00029. eCollection 2022 Apr 20.
2
Noble Metal Nanoparticles for Point-of-Care Testing: Recent Advancements and Social Impacts.用于即时检测的贵金属纳米颗粒:最新进展与社会影响
Bioengineering (Basel). 2022 Nov 8;9(11):666. doi: 10.3390/bioengineering9110666.
3
Application of Microfluidics in Drug Development from Traditional Medicine.
蛋白质和肽作为丁型肝炎免疫诊断的抗原候选物。
Amino Acids. 2025 Jul 4;57(1):35. doi: 10.1007/s00726-025-03465-2.
4
Nanobiosensors for revolutionizing parasitic infections diagnosis: a critical review to improve global health with an update on future challenges prospect.用于革新寄生虫感染诊断的纳米生物传感器:为改善全球健康的批判性综述及对未来挑战与前景的更新
Eur J Med Res. 2025 Jun 16;30(1):484. doi: 10.1186/s40001-025-02685-2.
5
Bionanotechnology: A Paradigm for Advancing Environmental Sustainability.生物纳米技术:推动环境可持续发展的范例。
Indian J Microbiol. 2025 Mar;65(1):306-332. doi: 10.1007/s12088-024-01389-1. Epub 2024 Sep 18.
6
Leveraging Nanoscience and Strategic Delivery for the Expedition of Osteoporosis.利用纳米科学与战略交付推动骨质疏松症研究进展
AAPS PharmSciTech. 2025 May 9;26(5):129. doi: 10.1208/s12249-025-03120-9.
7
Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy.揭示环状RNA的药物基因组学见解:迈向癌症治疗的精准医学
Biomolecules. 2025 Apr 5;15(4):535. doi: 10.3390/biom15040535.
8
Nanotechnology-based Approaches for Targeted Drug Delivery to the Small Intestine: Advancements and Challenges.基于纳米技术的小肠靶向给药方法:进展与挑战
Curr Pharm Des. 2025 Feb 10. doi: 10.2174/0113816128347722250109042022.
9
How Will Nanomedicine Revolutionize Future Dentistry and Periodontal Therapy?纳米医学将如何彻底改变未来的牙科和牙周治疗?
Int J Mol Sci. 2025 Jan 12;26(2):592. doi: 10.3390/ijms26020592.
10
Advances and Challenges in the Diagnosis of Leishmaniasis.利什曼病诊断的进展与挑战
Mol Diagn Ther. 2025 Mar;29(2):195-212. doi: 10.1007/s40291-024-00762-6. Epub 2025 Jan 22.
微流控技术在中药药物开发中的应用。
Biosensors (Basel). 2022 Oct 13;12(10):870. doi: 10.3390/bios12100870.
4
Nanoparticle-Based Visual Detection of Amplified DNA for Diagnosis of Hepatitis C Virus.基于纳米粒子的扩增 DNA 可视化检测在丙型肝炎病毒诊断中的应用。
Biosensors (Basel). 2022 Sep 9;12(9):744. doi: 10.3390/bios12090744.
5
Role of Paper-Based Sensors in Fight against Cancer for the Developing World.纸质传感器在发展中国家对抗癌症中的作用。
Biosensors (Basel). 2022 Sep 7;12(9):737. doi: 10.3390/bios12090737.
6
Nanoparticle-based mobile biosensors for the rapid detection of sepsis biomarkers in whole blood.用于快速检测全血中脓毒症生物标志物的基于纳米颗粒的移动生物传感器。
Nanoscale Adv. 2020 Jan 22;2(3):1253-1260. doi: 10.1039/d0na00026d. eCollection 2020 Mar 17.
7
The Pivotal Role of Quantum Dots-Based Biomarkers Integrated with Ultra-Sensitive Probes for Multiplex Detection of Human Viral Infections.基于量子点的生物标志物与超灵敏探针整合在人类病毒感染多重检测中的关键作用。
Pharmaceuticals (Basel). 2022 Jul 17;15(7):880. doi: 10.3390/ph15070880.
8
Advanced wearable biosensors for the detection of body fluids and exhaled breath by graphene.基于石墨烯的用于检测体液和呼气的先进可穿戴生物传感器。
Mikrochim Acta. 2022 May 28;189(6):236. doi: 10.1007/s00604-022-05317-2.
9
Malaria diagnostic methods with the elimination goal in view.着眼消除目标的疟疾诊断方法。
Parasitol Res. 2022 Jul;121(7):1867-1885. doi: 10.1007/s00436-022-07512-9. Epub 2022 Apr 23.
10
Multifunctional carbon nanomaterials for diagnostic applications in infectious diseases and tumors.用于传染病和肿瘤诊断应用的多功能碳纳米材料。
Mater Today Bio. 2022 Mar;14:100231. doi: 10.1016/j.mtbio.2022.100231. Epub 2022 Mar 5.